Skip to main content
. 2024 Apr 5;13(7):2116. doi: 10.3390/jcm13072116

Table 4.

Summary of advanced treatments for tattoos in SoC based on recent studies.

Author Study Type Year Laser Therapy Parameters Fitzpatrick Scale No. of Cases Clinical Outcome Adverse Events
Sirithanabadeekul et al. [47] RCT 2022 Fractionated 1064-nm picosecond lasers and unfractional 1064-nm ps-laser 1064-nm ps-laser: fluence 1.5–7.24 J/cm2; 3–4.5 mm spot, 2–5 Hz; fractionated 1064-nm ps-lasers: fluence 0.8 J/cm2; 8 mm spot, 2–5 Hz III–V 11 The combination side showed greater clearance scores and fewer adverse events than the side of unfractional 1064-nm picosecond laser alone. Temporary crusting, purpura, edema, erythema, burning sensation, and petechiae
Kasai et al. [45] Retrospective case series 2017 Multi-colored tattoos with a ps 755 nm Alexandrite laser and a ps Nd:YAG laser / / 4 Ps-lasers require fewer sessions than ns-QS lasers for treating black-colored tattoos and are more efficient than ns-QS lasers for multi-colored tattoos. Transient PIH in 1 patient
Kauvar et al. [49] Prospective clinical study 2017 Dual-wavelength, 1064/532-nm, ps-laser Both wavelengths are used on the same tattoo. Spot sizes 2 to 6 mm, maximum fluence 1.9 J/cm2 for 532-nm and 8.5 J/cm2 for 1064-nm handpieces Only 26% of subjects were non-Caucasian 34 (34 subjects with 39 tattoos) 86% (31 of 36 tattoos) showed at least a 50% clearance after three treatments. Patient satisfaction and treatment tolerability were high. Adverse events were few and transient in nature.
Sirithanabadeekul et al. [47] RCT 2022 Fractionated 1064-nm picosecond lasers and unfractional 1064-nm ps-laser 1064-nm ps-laser: fluence 1.5–7.24 J/cm2; 3–4.5 mm spot, 2–5 Hz; fractionated 1064-nm ps-lasers: fluence 0.8 J/cm2; 8 mm spot, 2–5 Hz III–V 11 The combination side showed greater clearance scores and fewer adverse events than the side of unfractional 1064-nm picosecond laser alone. Temporary crusting, purpura, edema, erythema, burning sensation, and petechiae

/ Refers to details not mentioned in study.